HRP970525A2 - Method for puryfying gbs toxin/cm101 - Google Patents

Method for puryfying gbs toxin/cm101

Info

Publication number
HRP970525A2
HRP970525A2 HR08/744,770A HRP970525A HRP970525A2 HR P970525 A2 HRP970525 A2 HR P970525A2 HR P970525 A HRP970525 A HR P970525A HR P970525 A2 HRP970525 A2 HR P970525A2
Authority
HR
Croatia
Prior art keywords
toxin
pure
hic
approximately
contacting
Prior art date
Application number
HR08/744,770A
Other languages
English (en)
Croatian (hr)
Inventor
Carl G Hellerqvist
Original Assignee
Carl G. Hellerqvist
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carl G. Hellerqvist filed Critical Carl G. Hellerqvist
Publication of HRP970525A2 publication Critical patent/HRP970525A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HR08/744,770A 1996-09-30 1997-09-29 Method for puryfying gbs toxin/cm101 HRP970525A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/744,770 US5811403A (en) 1996-09-30 1996-09-30 Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity

Publications (1)

Publication Number Publication Date
HRP970525A2 true HRP970525A2 (en) 1998-08-31

Family

ID=24993931

Family Applications (1)

Application Number Title Priority Date Filing Date
HR08/744,770A HRP970525A2 (en) 1996-09-30 1997-09-29 Method for puryfying gbs toxin/cm101

Country Status (18)

Country Link
US (4) US5811403A (de)
EP (1) EP0932696B1 (de)
JP (2) JP2001504144A (de)
KR (1) KR20000048757A (de)
CN (1) CN1192115C (de)
AR (1) AR011238A1 (de)
AT (1) ATE284449T1 (de)
AU (1) AU4802697A (de)
BR (1) BR9712167A (de)
CA (1) CA2265696C (de)
DE (1) DE69731891T2 (de)
DK (1) DK0932696T3 (de)
ES (1) ES2235228T3 (de)
HR (1) HRP970525A2 (de)
IL (1) IL129162A0 (de)
NO (1) NO991529L (de)
WO (1) WO1998014603A1 (de)
ZA (1) ZA978754B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811403A (en) * 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity
US5981508A (en) * 1997-01-29 1999-11-09 Vanderbilt University Facilitation of repair of neural injury with CM101/GBS toxin
US5858991A (en) * 1997-01-29 1999-01-12 Vanderbilt University Facilitation of wound healing with CM101/GBS toxin
US6028060A (en) 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US6803448B1 (en) 1998-07-22 2004-10-12 Vanderbilt University GBS toxin receptor
CA2333466C (en) * 1998-07-22 2012-05-01 Vanderbilt University Gbs toxin receptor
US8609614B2 (en) * 1998-07-22 2013-12-17 Vanderbilt University GBS toxin receptor compositions and methods of use
CN100540675C (zh) * 2006-12-06 2009-09-16 云南沃森生物技术有限公司 一种使用Sepharose 4FF凝胶对细菌多糖进行纯化的方法
EP2409995A3 (de) 2007-02-28 2012-08-15 Lipoxen Technologies Limited Reduktion von Endotoxin aus Polysialinsäuren
CN102757516B (zh) * 2012-08-03 2014-06-18 常州千红生化制药股份有限公司 依诺肝素钠的脱色方法
US10905783B2 (en) 2015-11-27 2021-02-02 Michal RIVLIN Glucosamine and derivatives thereof in imaging
CN114702558B (zh) * 2022-04-06 2023-09-15 四川奥邦投资有限公司 一种新型葡甘杂聚糖肽及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS557014A (en) * 1978-06-29 1980-01-18 Chugai Pharmaceut Co Ltd Antitumor agent and its preparation
JPS5740503A (en) * 1980-08-22 1982-03-06 Seikagaku Kogyo Co Ltd Separation of saccharides
US5059654A (en) * 1983-02-14 1991-10-22 Cuno Inc. Affinity matrices of modified polysaccharide supports
US4882317A (en) * 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4771128A (en) * 1986-10-10 1988-09-13 Cetus Corporation Method of purifying toxin conjugates using hydrophobic interaction chromatography
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5050062A (en) * 1989-02-06 1991-09-17 Hass David N Temperature controlled fluid system
US5010062A (en) 1989-09-25 1991-04-23 Vanderbilt University Therapeutic agent and method of inhibiting vascularization of tumors
US5225331A (en) * 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
US5811403A (en) * 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity

Also Published As

Publication number Publication date
WO1998014603A1 (en) 1998-04-09
ZA978754B (en) 1998-03-23
US6136789A (en) 2000-10-24
IL129162A0 (en) 2000-02-17
KR20000048757A (ko) 2000-07-25
AU4802697A (en) 1998-04-24
CA2265696C (en) 2009-12-08
BR9712167A (pt) 2000-01-18
US5811403A (en) 1998-09-22
CN1192115C (zh) 2005-03-09
HK1025602A1 (en) 2000-11-17
DE69731891D1 (de) 2005-01-13
EP0932696A1 (de) 1999-08-04
JP2009173945A (ja) 2009-08-06
EP0932696B1 (de) 2004-12-08
CA2265696A1 (en) 1998-04-09
DE69731891T2 (de) 2005-12-01
ES2235228T3 (es) 2005-07-01
US6407069B1 (en) 2002-06-18
NO991529L (no) 1999-05-19
NO991529D0 (no) 1999-03-29
JP2001504144A (ja) 2001-03-27
US5939396A (en) 1999-08-17
DK0932696T3 (da) 2005-03-14
AR011238A1 (es) 2000-08-16
ATE284449T1 (de) 2004-12-15
CN1235642A (zh) 1999-11-17

Similar Documents

Publication Publication Date Title
JP2009173945A (ja) Ｇｂｓトキシン／ｃｍ１０１の精製方法
EP2226336B1 (de) Bakterielle Kapsel-Polysaccharide für die Verwendung als Impfstoffe oder als Impfstoffe-Konjugat
JP2021193103A (ja) ボツリヌス神経毒素を得るためのプロセスおよびシステム
US20090060904A1 (en) Vegetarian Protein A Preparation and Methods Thereof
Tai et al. Isolation of type-specific polysaccharide antigen from group B type Ib streptococci.
NZ566871A (en) Protein A Production and Purification without Using Animal Derived Components involving staphylococcus aureus
JPH03169893A (ja) 精製方法
Hollingdale et al. Membrane antigens of Mycoplasma hominis
Lopez-Merino et al. Immunization by an insoluble fraction extracted from Brucella melitensis: immunological and chemical characterization of the active substances
Holmgren et al. Immunochemical studies of two cholera toxin-containing standard culture filtrate preparations of Vibrio cholerae
US4513083A (en) Preparation of an antibiotic selectively effective against staphylococcus infections
久米勝己 et al. Dissociation of Pasteurella multocida dermonecrotic toxin into three polypeptide fragments.
HK1025602B (en) Method for purifying gbs toxin/cm101
WO2025111258A1 (en) Clostridium botulinum neurotoxin serotype a compositions and improved filtration processes
Al-Thwani The Differences in Bioactivity between Crude and Purified Cholera Toxin from Local Isolate of Vibrio cholera: Amina, N. Al-Thwani1 and Khlood, A. Al-Khafaji
Lehrer et al. Characterization of Thermoactinomyces sacchari antigens
Loyer et al. Comparative study of hemolytic substances produced by coagulase-negative Staphylococcus strains
CN116270764A (zh) 一种含有长双歧杆菌胞外多糖的益生菌复合制剂在预防和治疗结肠炎中的应用
JPH0523754B2 (de)
HK1147506B (en) Bacterial capsular polysaccharide for use as vaccines or for linking to proteins in conjugate vaccines
JPH03184995A (ja) 抗腫瘍剤

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBI Application refused